Acosta-Baena N, Sepulveda-Falla D, Lopera-Gómez CM, Jaramillo-Elorza MC, Moreno S, Aguirre-Acevedo DC et al (2011) Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer’s disease: a retrospective cohort study. Lancet Neurol 10:213–220. https://doi.org/10.1016/S1474-4422(10)70323-9

Article  CAS  PubMed  Google Scholar 

Aguirre-Acevedo DC, Lopera F, Henao E, Tirado V, Muñoz C, Giraldo M et al (2016) Cognitive decline in a colombian kindred with autosomal dominant Alzheimer disease a retrospective cohort study. JAMA Neurol 73:431–438. https://doi.org/10.1001/jamaneurol.2015.4851

Article  PubMed  PubMed Central  Google Scholar 

Almeida MC, Eger SJ, He C, Audouard M, Nikitina A, Glasauer SMK et al (2024) Single-nucleus RNA sequencing demonstrates an autosomal dominant Alzheimer’s disease profile and possible mechanisms of disease protection. Neuron 112:1778-1794.e7. https://doi.org/10.1016/j.neuron.2024.02.009

Article  CAS  PubMed  PubMed Central  Google Scholar 

Appleton J, Finn Q, Zanotti-Fregonara P, Yu M, Faridar A, Nakawah MO et al (2024) Brain inflammation co-localizes highly with tau in mild 2 cognitive impairment due to early-onset Alzheimer’s disease. Brain

Attar A, Liu T, Chan WTC, Hayes J, Nejad M, Lei KC et al (2013) A shortened barnes maze protocol reveals memory deficits at 4-months of age in the triple-transgenic mouse model of Alzheimer’s disease. PLoS ONE. https://doi.org/10.1371/journal.pone.0080355

Article  PubMed  PubMed Central  Google Scholar 

Barron AM, Tokunaga M, Zhang MR, Ji B, Suhara T, Higuchi M (2016) Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET. J Neuroinflammation 13:1–14. https://doi.org/10.1186/s12974-016-0700-x

Article  CAS  Google Scholar 

Betlazar C, Harrison-Brown M, Middleton RJ, Banati R, Liu GJ (2018) Cellular sources and regional variations in the expression of the neuroinflammatory marker translocator protein (TSPO) in the normal brain. Int J Mol Sci. https://doi.org/10.3390/ijms19092707

Article  PubMed  PubMed Central  Google Scholar 

Biechele G, Franzmeier N, Blume T, Ewers M, Luque JM, Eckenweber F et al (2020) Glial activation is moderated by sex in response to amyloidosis but not to tau pathology in mouse models of neurodegenerative diseases. J Neuroinflammation 17:1–10. https://doi.org/10.1186/s12974-020-02046-2

Article  CAS  Google Scholar 

Botella Lucena P, Vanherle S, Lodder C, Gutiérrez de Ravé M, Stancu IC, Lambrichts I et al (2022) Blood-based Aβ42 increases in the earliest pre-pathological stage before decreasing with progressive amyloid pathology in preclinical models and human subjects: opening new avenues for prevention. Acta Neuropathol 144:489–508. https://doi.org/10.1007/s00401-022-02458-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bradburn S, Murgatroyd C, Ray N (2019) Neuroinflammation in mild cognitive impairment and Alzheimer’s disease: a meta-analysis. Ageing Res Rev 50:1–8. https://doi.org/10.1016/j.arr.2019.01.002

Article  CAS  PubMed  Google Scholar 

Brendel M, Probst F, Jaworska A, Overhoff F, Korzhova V, Albert NL et al (2016) Glial activation and glucose metabolism in a transgenic amyloid mouse model: a triple-tracer PET study. J Nucl Med 57:954–960. https://doi.org/10.2967/jnumed.115.167858

Article  CAS  PubMed  Google Scholar 

Canário N, Jorge L, Martins R, Santana I, Castelo-Branco M (2022) Dual PET-fMRI reveals a link between neuroinflammation, amyloid binding and compensatory task-related brain activity in Alzheimer’s disease. Commun Biol 5:1–7. https://doi.org/10.1038/s42003-022-03761-7

Article  CAS  Google Scholar 

Carlesimo GA, Piras F, Orfei MD, Iorio M, Caltagirone C, Spalletta G (2015) Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer’s disease. Alzheimer’s Dement Diagnosis, Assess Dis Monit 1:24–32. https://doi.org/10.1016/j.dadm.2014.12.001

Article  Google Scholar 

Chaney A, Bauer M, Bochicchio D, Smigova A, Kassiou M, Davies KE et al (2018) Longitudinal investigation of neuroinflammation and metabolite profiles in the APP swe ×PS1 Δe9 transgenic mouse model of Alzheimer’s disease. J Neurochem 144:318–335. https://doi.org/10.1111/jnc.14251

Article  CAS  PubMed  Google Scholar 

Chatterjee P, Pedrini S, Doecke JD, Thota R, Villemagne VL, Doré V et al (2023) Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer’s disease continuum: a cross-sectional and longitudinal study in the AIBL cohort. Alzheimer’s Dement 19:1117–1134. https://doi.org/10.1002/alz.12724

Article  CAS  Google Scholar 

Chauveau F, Boutin H, Van Camp N, Dollé F, Tavitian B (2008) Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers. Eur J Nucl Med Mol Imaging 35:2304–2319. https://doi.org/10.1007/s00259-008-0908-9

Article  PubMed  Google Scholar 

Chen MK, Guilarte TR (2008) Translocator protein 18 kDa (TSPO): Molecular sensor of brain injury and repair. Pharmacol Ther 118:1–17. https://doi.org/10.1016/j.pharmthera.2007.12.004

Article  CAS  PubMed  PubMed Central  Google Scholar 

Clayton K, Delpech JC, Herron S, Iwahara N, Ericsson M, Saito T et al (2021) Correction to: Plaque associated microglia hyper-secrete extracellular vesicles and accelerate tau propagation in a humanized APP mouse model (Molecular Neurodegeneration, (2021), 16, 1, (18), DOI: 10.1186/s13024-021-00440-9). Mol Neurodegener 16:1–16. https://doi.org/10.1186/s13024-021-00447-2

Article  Google Scholar 

Costa J, Martins S, Ferreira PA, Cardoso AMS, Guedes JR, Peça J et al (2021) The old guard: age-related changes in microglia and their consequences. Mech Ageing Dev. https://doi.org/10.1016/j.mad.2021.111512

Article  PubMed  Google Scholar 

d’Errico P, Ziegler-Waldkirch S, Aires V, Hoffmann P, Mezö C, Erny D et al (2022) Microglia contribute to the propagation of Aβ into unaffected brain tissue. Nat Neurosci 25:20–25. https://doi.org/10.1038/s41593-021-00951-0

Article  CAS  PubMed  Google Scholar 

Doecke JD, Pérez-Grijalba V, Fandos N, Fowler C, Villemagne VL, Masters CL et al (2020) Total Aβ42/Aβ40 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis. Neurology 94:E1580–E1591. https://doi.org/10.1212/WNL.0000000000009240

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dokholyan NV, Mohs RC, Bateman RJ (2022) Challenges and progress in research, diagnostics, and therapeutics in Alzheimer’s disease and related dementias. Alzheimer’s Dement Transl Res Clin Interv 8:1–5. https://doi.org/10.1002/trc2.12330

Article  Google Scholar 

Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM et al (2012) Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer’s disease kindred: a cross-sectional study. Lancet Neurol 11:1057–1065. https://doi.org/10.1016/S1474-4422(12)70227-2

Article  CAS  PubMed  Google Scholar 

Floden AM, Combs CK (2011) Microglia demonstrate age-dependent interaction with amyloid-β fibrils. J Alzheimer’s Dis 25:279–293. https://doi.org/10.3233/JAD-2011-101014

Article  CAS  Google Scholar 

Focke C, Blume T, Zott B, Shi Y, Deussing M, Peters F et al (2019) Early and longitudinal microglial activation but not amyloid accumulation predicts cognitive outcome in PS2APp mice. J Nucl Med 60:548–554. https://doi.org/10.2967/jnumed.118.217703

Article  CAS  PubMed  Google Scholar 

Forner S, Kawauchi S, Balderrama-Gutierrez G, Kramár EA, Matheos DP, Phan J et al (2021) Systematic phenotyping and characterization of the 5xFAD mouse model of Alzheimer’s disease. Sci Data 8:1–16. https://doi.org/10.1038/s41597-021-01054-y

Article  CAS  Google Scholar 

Garland EF, Antony H, Kulagowska L, Scott T, Rogien C, Bottlaender M et al (2024) The microglial translocator protein (TSPO) in Alzheimer’s disease reflects a phagocytic phenotype. Acta Neuropathol. https://doi.org/10.1007/s00401-024-02822-x

Article  PubMed  PubMed Central  Google Scholar 

Garland EF, Dennett O, Lau LC, Chatelet DS, Bottlaender M, Nicoll JAR et al (2023) The mitochondrial protein TSPO in Alzheimer’s disease: relation to the severity of AD pathology and the neuroinflammatory environment. J Neuroinflammation 20:1–15. https://doi.org/10.1186/s12974-023-02869-9

Article  CAS  Google Scholar 

Giudici KV, De Souto BP, Guyonnet S, Li Y, Bateman RJ, Vellas B (2020) Assessment of plasma amyloid-β42/40and cognitive decline among community-dwelling older adults. JAMA Netw Open 3:1–13. https://doi.org/10.1001/jamanetworkopen.2020.28634